These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9327918)

  • 1. Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase.
    Scheinin M; Illi A; Koulu M; Ojala-Karlsson P
    Adv Pharmacol; 1998; 42():367-70. PubMed ID: 9327918
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
    Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
    Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.
    Doudet DJ; Chan GL; Holden JE; Pate BD; Morrison KS; Calne DB; Ruth TJ
    Eur J Pharmacol; 1997 Sep; 334(1):31-8. PubMed ID: 9346324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
    Dingemanse J; Kneer J; Wallnöfer A; Kettler R; Zürcher G; Koulu M; Korn A
    Clin Neuropharmacol; 1996 Oct; 19(5):399-414. PubMed ID: 8889283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
    Lyytinen J; Kaakkola S; Ahtila S; Tuomainen P; Teräväinen H
    Mov Disord; 1997 Jul; 12(4):497-505. PubMed ID: 9251066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands.
    Lalies MD; Hibell A; Hudson AL; Nutt DJ
    Ann N Y Acad Sci; 1999 Jun; 881():114-7. PubMed ID: 10415906
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
    Berlin I; Zimmer R; Thiede HM; Payan C; Hergueta T; Robin L; Puech AJ
    Br J Clin Pharmacol; 1990 Dec; 30(6):805-16. PubMed ID: 1705137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
    Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
    Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the COMT inhibitor nitecapone for one week on exercise haemodynamics and catecholamine disposition.
    Sundberg S; Scheinin M; Ojala-Karlsson P; Akkila J; Gordin A
    Eur J Clin Pharmacol; 1993; 44(3):287-90. PubMed ID: 8491246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase and catechol-O-methyltransferase inhibitors.
    Siderowf A; Kurlan R
    Med Clin North Am; 1999 Mar; 83(2):445-67. PubMed ID: 10093587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone.
    Sundberg S; Scheinin M; Ojala-Karlsson P; Kaakkola S; Akkila J; Gordin A
    Clin Pharmacol Ther; 1990 Oct; 48(4):356-64. PubMed ID: 2225697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers.
    Scheinin M; Koulu M; Karhuvaara S; Zimmer RH
    Life Sci; 1990; 47(16):1491-9. PubMed ID: 2250565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide.
    Cesura AM; Kettler R; Imhof R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S15-6. PubMed ID: 1546132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
    Hovevey-Sion D; Kopin IJ; Stull RW; Goldstein DS
    Neuropharmacology; 1989 Aug; 28(8):791-7. PubMed ID: 2506486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, conformational analysis and antidepressant activity of moclobemide new analogues.
    Ghanbarpour A; Hadizadeh F; Piri F; Rashidi-Ranjbar P
    Pharm Acta Helv; 1997 Apr; 72(2):119-22. PubMed ID: 9112832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats.
    Burkard W; d'Agostini F; Kettler R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S35-6. PubMed ID: 1546137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.
    Müller T
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1423-32. PubMed ID: 25196265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers.
    Scheinin M; Karhuvaara S; Ojala-Karlsson P; Kallio A; Koulu M
    Life Sci; 1991; 49(1):75-84. PubMed ID: 1646924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.